Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (404)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
138
4.530
Why?
Carcinoma in Situ
7
2022
72
1.970
Why?
Uterine Neoplasms
10
2023
60
1.960
Why?
Vulvar Neoplasms
5
2022
52
1.900
Why?
Carcinoma, Endometrioid
6
2021
38
1.630
Why?
Adenocarcinoma
10
2024
397
1.590
Why?
Carcinoma, Squamous Cell
8
2019
318
1.470
Why?
PAX2 Transcription Factor
7
2015
22
1.460
Why?
Uterine Cervical Neoplasms
7
2024
276
1.200
Why?
Ovarian Neoplasms
10
2024
447
1.190
Why?
Endometrial Hyperplasia
4
2019
14
1.150
Why?
Stromal Cells
2
2016
72
1.030
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.910
Why?
Cannabidiol
5
2024
38
0.890
Why?
Female
65
2024
26635
0.880
Why?
Myometrium
2
2013
14
0.860
Why?
Endometrium
6
2023
41
0.830
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.780
Why?
Precancerous Conditions
3
2019
83
0.760
Why?
Aged, 80 and over
20
2024
3154
0.730
Why?
Cystadenocarcinoma, Serous
4
2013
71
0.700
Why?
Plant Extracts
5
2024
171
0.690
Why?
Tumor Suppressor Protein p53
2
2017
203
0.660
Why?
Humans
68
2024
50208
0.640
Why?
Middle Aged
34
2024
12206
0.630
Why?
Peripheral Nerves
2
2015
49
0.630
Why?
Aged
29
2024
9405
0.600
Why?
Mutation
9
2024
1294
0.600
Why?
Placenta
6
2021
132
0.580
Why?
Cervix Uteri
2
2017
49
0.570
Why?
Epithelial-Mesenchymal Transition
2
2016
48
0.570
Why?
Adult
31
2024
13324
0.560
Why?
Immunohistochemistry
15
2020
978
0.550
Why?
Adenosarcoma
1
2016
3
0.550
Why?
Cannabis
5
2024
145
0.550
Why?
Polyps
1
2016
21
0.540
Why?
Uterine Cervical Dysplasia
1
2016
49
0.530
Why?
Neoplasm Staging
9
2024
738
0.510
Why?
Lymphatic Metastasis
6
2019
227
0.510
Why?
Fibroma
1
2015
39
0.510
Why?
Fallopian Tubes
2
2012
22
0.500
Why?
Tumor Microenvironment
4
2021
233
0.500
Why?
Prognosis
11
2024
1954
0.460
Why?
Neoplasm Invasiveness
6
2019
266
0.450
Why?
Pelvic Neoplasms
1
2011
14
0.400
Why?
Uterus
3
2023
94
0.390
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
78
0.390
Why?
Ejaculatory Ducts
1
2010
3
0.360
Why?
Seminal Vesicles
1
2010
13
0.360
Why?
Neoplasm Recurrence, Local
4
2015
613
0.360
Why?
Spectrum Analysis, Raman
2
2021
58
0.350
Why?
Prostate
1
2010
117
0.340
Why?
Bromcresol Purple
1
2009
3
0.330
Why?
Electrophoresis, Capillary
1
2009
11
0.330
Why?
Serum Albumin
1
2009
58
0.320
Why?
Mice, Inbred C57BL
6
2024
1819
0.320
Why?
Human papillomavirus 16
2
2021
44
0.320
Why?
Methionine
2
2020
135
0.310
Why?
beta Catenin
2
2021
102
0.310
Why?
Disease Progression
4
2020
831
0.310
Why?
Mice
15
2024
5759
0.300
Why?
Diabetes Mellitus
2
2023
286
0.300
Why?
Papillomavirus Infections
2
2022
155
0.300
Why?
Papillomavirus Vaccines
2
2021
61
0.290
Why?
Genital Neoplasms, Female
2
2018
41
0.290
Why?
Anus Neoplasms
2
2018
24
0.290
Why?
Metaplasia
2
2019
16
0.290
Why?
Cell Proliferation
4
2021
1013
0.280
Why?
Antigens, CD
2
2019
221
0.280
Why?
Diagnosis, Differential
8
2020
1043
0.280
Why?
Prostatic Neoplasms
1
2010
394
0.270
Why?
Colitis
2
2020
51
0.270
Why?
Polyethylene Glycols
2
2017
93
0.260
Why?
Melanoma
2
2020
290
0.260
Why?
Neoplasm Grading
5
2021
123
0.260
Why?
Hypertension
2
2021
537
0.260
Why?
Chi-Square Distribution
2
2016
278
0.250
Why?
Gold
2
2017
136
0.250
Why?
Proteomics
3
2017
330
0.240
Why?
Nanoparticles
2
2017
152
0.240
Why?
Young Adult
7
2024
3981
0.240
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.240
Why?
Racemases and Epimerases
2
2015
15
0.240
Why?
Retrospective Studies
11
2020
6134
0.240
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.240
Why?
Neuroendocrine Tumors
1
2024
23
0.230
Why?
Carcinoma, Neuroendocrine
1
2024
24
0.230
Why?
Animals
16
2024
13246
0.230
Why?
Head and Neck Neoplasms
2
2019
273
0.230
Why?
DNA Mutational Analysis
3
2024
176
0.230
Why?
Kidney Neoplasms
2
2018
176
0.220
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
41
0.220
Why?
Homeodomain Proteins
1
2024
80
0.220
Why?
Chlamydia muridarum
1
2024
41
0.220
Why?
Lung Neoplasms
2
2019
605
0.220
Why?
Endometriosis
1
2023
14
0.220
Why?
Gynecology
2
2020
49
0.210
Why?
Chlamydia Infections
1
2024
77
0.210
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.210
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.210
Why?
Observer Variation
3
2017
129
0.210
Why?
CD4-Positive T-Lymphocytes
1
2024
164
0.210
Why?
Fallopian Tube Neoplasms
2
2012
14
0.200
Why?
Immunotherapy
2
2021
240
0.200
Why?
Gestational Trophoblastic Disease
2
2012
2
0.200
Why?
Genotype
2
2021
534
0.200
Why?
CTLA-4 Antigen
1
2021
25
0.200
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.190
Why?
Oncogene Fusion
1
2021
4
0.190
Why?
PTEN Phosphohydrolase
3
2020
55
0.190
Why?
Estrogens
2
2023
228
0.190
Why?
Leiomyosarcoma
1
2021
23
0.190
Why?
Transcription Factors
3
2020
564
0.190
Why?
Diabetes, Gestational
1
2021
52
0.190
Why?
Cancer Vaccines
1
2021
78
0.190
Why?
Carcinosarcoma
2
2017
18
0.180
Why?
Infant, Small for Gestational Age
1
2020
34
0.180
Why?
Carcinoma, Papillary
1
2020
49
0.180
Why?
Neoplasms, Experimental
1
2020
114
0.180
Why?
Carcinoma, Transitional Cell
1
2020
52
0.180
Why?
Colonic Neoplasms
1
2021
159
0.170
Why?
Pregnancy in Diabetics
1
2020
29
0.170
Why?
Dermatology
1
2020
49
0.170
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.170
Why?
Pregnancy Complications, Neoplastic
1
2019
22
0.170
Why?
Carcinoma, Lewis Lung
1
2019
10
0.170
Why?
Radiotherapy
1
2020
127
0.170
Why?
Placenta Diseases
1
2019
14
0.170
Why?
Carcinoma, Renal Cell
2
2018
105
0.170
Why?
Skin Diseases
1
2020
111
0.170
Why?
Hepatic Veno-Occlusive Disease
1
2019
10
0.170
Why?
Premature Birth
1
2021
147
0.170
Why?
Odds Ratio
3
2015
546
0.170
Why?
Hodgkin Disease
1
2019
44
0.170
Why?
DNA Polymerase II
1
2019
9
0.170
Why?
DNA Mismatch Repair
1
2019
16
0.170
Why?
Melanoma, Experimental
1
2019
45
0.170
Why?
Inflammation
2
2020
604
0.170
Why?
Fetal Diseases
1
2019
61
0.170
Why?
T-Lymphocytes
1
2021
339
0.160
Why?
Sarcoma
1
2020
67
0.160
Why?
Monocytes
1
2019
131
0.160
Why?
Urinary Bladder Neoplasms
1
2020
156
0.160
Why?
Reproducibility of Results
4
2017
1185
0.160
Why?
Metformin
1
2020
65
0.160
Why?
Pregnancy
7
2021
2604
0.160
Why?
Methionine Adenosyltransferase
1
2018
19
0.160
Why?
CD8-Positive T-Lymphocytes
1
2019
128
0.160
Why?
Logistic Models
3
2015
889
0.160
Why?
Nuclear Proteins
1
2020
243
0.150
Why?
Hypoglycemic Agents
1
2020
168
0.150
Why?
Radiation Tolerance
1
2019
85
0.150
Why?
Disease Models, Animal
6
2020
1458
0.150
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.150
Why?
Rhabdomyosarcoma
1
2018
13
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
39
0.150
Why?
DNA Helicases
1
2020
144
0.150
Why?
Intestinal Mucosa
2
2020
215
0.150
Why?
Pathology, Molecular
1
2017
22
0.150
Why?
Hepatocytes
1
2019
182
0.150
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
66
0.150
Why?
Biopsy
5
2020
590
0.150
Why?
Tumor Necrosis Factor-alpha
2
2019
388
0.150
Why?
Liver
3
2024
1116
0.150
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2017
55
0.150
Why?
Pregnancy Complications
1
2021
382
0.140
Why?
Osteosarcoma
1
2017
47
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.140
Why?
Vimentin
1
2016
32
0.140
Why?
Gene Expression Profiling
2
2019
1037
0.140
Why?
Papillomaviridae
1
2017
102
0.140
Why?
Time Factors
3
2021
2922
0.140
Why?
Acetaminophen
1
2019
283
0.140
Why?
Oligonucleotide Array Sequence Analysis
1
2017
411
0.130
Why?
DNA-Binding Proteins
2
2016
428
0.130
Why?
Cadherins
1
2016
68
0.130
Why?
Viral Load
1
2016
77
0.130
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.130
Why?
Skin Neoplasms
1
2020
492
0.130
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.120
Why?
Malate Dehydrogenase
1
2014
9
0.120
Why?
Classification
1
2015
14
0.120
Why?
Colposcopy
1
2015
18
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
18
0.120
Why?
Lipogenesis
1
2014
29
0.120
Why?
World Health Organization
1
2015
48
0.120
Why?
Flow Cytometry
1
2017
476
0.120
Why?
Cytosol
1
2014
82
0.120
Why?
Mice, Inbred BALB C
3
2021
305
0.120
Why?
Adolescent
4
2024
6390
0.120
Why?
Neoplasm, Residual
1
2015
165
0.120
Why?
Mammary Neoplasms, Experimental
1
2015
121
0.120
Why?
Histones
1
2016
313
0.120
Why?
Obesity
1
2022
1108
0.120
Why?
High-Throughput Nucleotide Sequencing
3
2021
170
0.120
Why?
Multiple Myeloma
1
2009
2954
0.120
Why?
Antineoplastic Agents
2
2021
1186
0.110
Why?
Gastrointestinal Tract
1
2014
101
0.110
Why?
Male
10
2024
25399
0.110
Why?
Intestines
1
2014
168
0.110
Why?
Oncogenes
1
2013
57
0.110
Why?
Patient Selection
1
2015
253
0.110
Why?
Cell Line, Tumor
4
2020
1416
0.110
Why?
Clusterin
1
2012
6
0.110
Why?
Predictive Value of Tests
4
2018
905
0.110
Why?
Membrane Proteins
1
2015
353
0.110
Why?
Risk Factors
3
2015
3629
0.110
Why?
Pancreatic Neoplasms
1
2015
208
0.110
Why?
Histocytochemistry
1
2012
47
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
22
0.100
Why?
Strongyloidiasis
1
2012
10
0.100
Why?
Follow-Up Studies
2
2016
2190
0.100
Why?
Treatment Outcome
3
2021
5155
0.100
Why?
Cytomegalovirus Infections
1
2012
35
0.100
Why?
Prednisone
1
2012
101
0.100
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.100
Why?
Vascular Endothelial Growth Factor A
1
2012
202
0.100
Why?
Teratoma
1
2011
26
0.100
Why?
Matrix Metalloproteinases
1
2011
48
0.090
Why?
Sensitivity and Specificity
3
2020
863
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
246
0.090
Why?
Phenotype
3
2019
733
0.090
Why?
Tissue Array Analysis
3
2015
45
0.090
Why?
Glucocorticoids
1
2012
226
0.090
Why?
Tumor Cells, Cultured
2
2021
468
0.080
Why?
Epigenesis, Genetic
1
2012
378
0.080
Why?
Pregnancy Outcome
2
2021
237
0.080
Why?
Pilot Projects
2
2023
697
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
140
0.080
Why?
Infant, Newborn
3
2021
2766
0.080
Why?
Telemedicine
1
2015
449
0.080
Why?
Necrosis
2
2024
178
0.080
Why?
Cell Differentiation
2
2024
650
0.080
Why?
Hysterectomy
2
2021
88
0.080
Why?
Cell Nucleus
2
2021
187
0.080
Why?
Societies, Medical
2
2019
177
0.070
Why?
Host-Pathogen Interactions
2
2021
135
0.070
Why?
Neoplasms
1
2017
1249
0.070
Why?
Gene Expression Regulation
3
2023
979
0.070
Why?
Consensus
2
2020
150
0.070
Why?
Ventricular Pressure
1
2006
16
0.070
Why?
Isoproterenol
1
2006
56
0.070
Why?
Terminology as Topic
2
2018
62
0.070
Why?
Kaplan-Meier Estimate
2
2018
465
0.070
Why?
Serum Response Factor
1
2006
42
0.070
Why?
Combined Modality Therapy
2
2020
636
0.070
Why?
Kidney
1
2010
672
0.070
Why?
Practice Guidelines as Topic
2
2019
449
0.070
Why?
Neoplasm Metastasis
2
2018
236
0.060
Why?
Cytokines
2
2020
613
0.060
Why?
Cells, Cultured
2
2021
1581
0.060
Why?
Proportional Hazards Models
2
2017
410
0.060
Why?
Chromatography, Liquid
2
2016
225
0.060
Why?
Bilirubin
1
2024
40
0.060
Why?
Tandem Mass Spectrometry
2
2016
231
0.060
Why?
Species Specificity
1
2024
192
0.060
Why?
Dose-Response Relationship, Drug
2
2019
1378
0.060
Why?
Heart
1
2006
331
0.060
Why?
Steroids
1
2024
57
0.060
Why?
Th1 Cells
1
2024
52
0.060
Why?
Interleukin-10
1
2024
84
0.060
Why?
Phylogeny
1
2024
234
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
828
0.050
Why?
Government Agencies
1
2022
14
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
64
0.050
Why?
Hemorrhage
1
2024
197
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
11
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Parturition
1
2021
51
0.050
Why?
Phthalazines
1
2021
20
0.050
Why?
Remission Induction
1
2021
207
0.050
Why?
Quinazolines
1
2021
33
0.050
Why?
Lymphocyte Activation
1
2021
172
0.050
Why?
Vulva
1
2020
17
0.050
Why?
Taurine
1
2020
15
0.050
Why?
Research Report
1
2020
16
0.050
Why?
Metabolic Networks and Pathways
1
2021
89
0.050
Why?
Herb-Drug Interactions
1
2020
31
0.050
Why?
Mucin-2
1
2020
7
0.050
Why?
Toxicity Tests
1
2020
54
0.050
Why?
Alkaline Phosphatase
1
2020
95
0.040
Why?
Molecular Targeted Therapy
1
2021
121
0.040
Why?
Risk
1
2021
324
0.040
Why?
Piperazines
1
2021
118
0.040
Why?
Chemokines
1
2020
78
0.040
Why?
United States
3
2016
4874
0.040
Why?
Birth Weight
1
2020
120
0.040
Why?
Preoperative Period
1
2020
47
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
36
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
595
0.040
Why?
Colon
1
2020
94
0.040
Why?
Endothelium
1
2019
39
0.040
Why?
Pyrimidines
1
2021
193
0.040
Why?
Chest Pain
1
2019
55
0.040
Why?
Receptors, Progesterone
1
2020
64
0.040
Why?
Mice, Transgenic
2
2014
550
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
32
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
63
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
195
0.040
Why?
Glutamine
1
2020
171
0.040
Why?
Dyspnea
1
2019
75
0.040
Why?
Estrogen Receptor alpha
1
2020
89
0.040
Why?
Liver Function Tests
1
2019
47
0.040
Why?
Fatal Outcome
1
2019
195
0.040
Why?
Mice, Inbred Strains
1
2019
161
0.040
Why?
Drug Synergism
1
2019
151
0.040
Why?
Gestational Age
1
2020
418
0.040
Why?
Imaging, Three-Dimensional
1
2019
153
0.040
Why?
Mice, Nude
1
2019
254
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
212
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Nephrectomy
1
2018
83
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.040
Why?
Lymph Node Excision
1
2019
137
0.040
Why?
Cell Lineage
1
2018
84
0.040
Why?
Ultrasonography, Prenatal
1
2019
186
0.040
Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
Why?
DNA Copy Number Variations
1
2018
110
0.040
Why?
Skin
1
2020
415
0.040
Why?
Anal Canal
1
2017
21
0.040
Why?
Macrophages
1
2019
363
0.040
Why?
Dietary Supplements
1
2020
434
0.040
Why?
Child
2
2024
6851
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
35
0.030
Why?
Disease-Free Survival
1
2017
454
0.030
Why?
Lymph Nodes
1
2019
263
0.030
Why?
Transcriptome
1
2019
320
0.030
Why?
Telomerase
1
2016
27
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
49
0.030
Why?
Diet
1
2020
557
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Signal Transduction
1
2023
1622
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
86
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
115
0.030
Why?
S100 Proteins
1
2015
34
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
63
0.030
Why?
Cell Count
1
2015
149
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Pressure
1
2015
106
0.030
Why?
Drug Evaluation, Preclinical
1
2015
143
0.030
Why?
Blood Vessels
1
2015
71
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
51
0.030
Why?
Genetic Predisposition to Disease
1
2018
509
0.030
Why?
Random Allocation
1
2015
282
0.030
Why?
Immunoenzyme Techniques
1
2014
145
0.030
Why?
Prospective Studies
1
2020
2379
0.030
Why?
Radiotherapy Dosage
1
2015
246
0.030
Why?
Proteome
1
2016
173
0.030
Why?
Apoptosis
1
2020
1112
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
181
0.030
Why?
Likelihood Functions
1
2014
54
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
259
0.030
Why?
Vaccination
1
2016
271
0.030
Why?
Multivariate Analysis
1
2015
581
0.030
Why?
Anti-Bacterial Agents
1
2019
747
0.030
Why?
Genes, erbB-1
1
2013
8
0.030
Why?
Lipid Metabolism
1
2014
175
0.030
Why?
Gene Frequency
1
2013
94
0.030
Why?
Adiposity
1
2014
133
0.030
Why?
SEER Program
1
2013
92
0.030
Why?
Communication
1
2015
246
0.030
Why?
Mesentery
1
2012
32
0.030
Why?
Rural Health Services
1
2015
164
0.030
Why?
Research Design
1
2015
342
0.030
Why?
Insulin Resistance
1
2014
262
0.030
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.030
Why?
Pregnancy Proteins
1
2012
5
0.030
Why?
Neoplasms, Glandular and Epithelial
1
2012
42
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
6
0.030
Why?
Socioeconomic Factors
1
2015
579
0.030
Why?
Angiopoietin-2
1
2012
15
0.030
Why?
Angiopoietin-1
1
2012
16
0.030
Why?
Diet, High-Fat
1
2014
220
0.030
Why?
Ovary
1
2012
115
0.030
Why?
Ivermectin
1
2012
9
0.030
Why?
Antiparasitic Agents
1
2012
10
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
32
0.030
Why?
Infant
1
2020
3563
0.020
Why?
Algorithms
1
2015
618
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
RNA, Messenger
1
2014
1108
0.020
Why?
Crohn Disease
1
2012
90
0.020
Why?
Isoenzymes
1
2011
169
0.020
Why?
Interleukin-6
1
2012
265
0.020
Why?
Promoter Regions, Genetic
1
2012
475
0.020
Why?
Gene Expression
1
2012
609
0.020
Why?
Risk Assessment
1
2015
1262
0.020
Why?
Radiography
1
2011
491
0.020
Why?
Cell Line
1
2012
1021
0.020
Why?
Cohort Studies
1
2013
1422
0.020
Why?
DNA Methylation
1
2012
550
0.020
Why?
Rats
1
2014
3299
0.020
Why?
Blotting, Western
1
2006
601
0.020
Why?
Myocardium
1
2006
438
0.010
Why?
Age Factors
1
2006
1092
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description